(Guest Lecture) Getting to Know HealthTree Connect - A New Social Networking Site for the Myeloma Community

(Guest Lecture) Interpreting MGUS/Smoldering Myeloma Labs - What to Know and When to Take Action

All about IVIG (Intravenous Immunoglobulin)

(Guest Lecture): January 2023 - Financial Preparing for Your 2022 Tax Filing

(Guest Lecture) Mezigdomide (CC-92480) | Paul Richardson, MD | ASH 2022

Individualized Prediction Model in Myeloma & Genome Sequencing | Francesco Maura, MD | ASH 2022

MODAKAFUSP ALFA (TAK-573) | Dan Vogl, MD, MSCE | ASH 2022

Opioid Use in Managing Pain in Myeloma | Karen Sweiss, PharmD | ASH 2022

Frailty and Multiple Myeloma | Hira Mian, MD, MSc | ASH 2022

MajesTEC-2 Trial | Emma Searle, MBChB MA MRCP FRCPath PhD | ASH 2022

Barriers to Participation in Hematology Trials | Shakira Grant, MBBS & Jiona Mills | ASH 2022

Talquetamab | Ajai Chari, MD | ASH 2022

OPTIMUM MUK Nine Trial | Martin Kaiser, MD | ASH 2022